NIIF is also launching its Master Fund II, targeting a commitment of about $3.5-4 billion. The New Development Bank (NDB) has committed $10...

NIIF is gearing up to secure approximately $1 billion for its second Private Markets Fund (PMF), according to people familiar with the matt...

Investors are paying close attention to the contrasting trajectories of two of Asia’s greatest powers. India, the world’s fastest-growing m...

U.S. asset manager Fidelity International is highlighting China's looser monetary policy and the government's recent 1 trillion yuan ($137....

"The investment is through a mix of primary (Rs 120 crore) and secondary (Rs 30 crore) sale," said Tushar Korday director, Emil Pharmaceuti...

Ujala Cygnus is controlled by leading media house Amar Ujala through its healthcare arm Medicive Healthcare. Ghoshal owns 25% in Medicive. ...

Several sectors remained attractive to investors, including FMCG, IT, pharma, financial services, etc. Some of the top countries from where...

The fragmented healthcare system has been under pressure, amplified by the Covid pandemic. Chronic care and elective surgeries took a beati...

The 57-year-old American billionaire, wearing a blue flight suit and donning a cowboy hat, was joined by three crewmates for a trip to the ...

The American billionaire is due to fly from a desert site in West Texas on an 11-minute voyage to the edge of space nine days after British...

Another company which works in a similar space in India include Kasiak Research, which is a part of Bharat Serums and Vaccines (BSVL).

VCs aim to close multiple deals despite a lack of clarity on regulatory issues in the segment

Proceeds from the Series B round of funding, which also saw participation from existing investor Artiman Ventures, will be used by the Gurg...

Cygnus Hospitals, which operates a chain of super speciality units in Delhi and Haryana, aims to add another 40 hospitals in north India.

Cygnus, whose promoters are four doctors, merged with Altius Healthcare in early 2013. The company reported revenues of Rs 68 crore in 2013...

The oversubscription of India Life Sciences Fund II shows that investors are open to funds offering focused expertise in certain key indust...

Somerset Capital's first fund, which raised $27 million (Rs 160 crore) is backed by US buyout firm Avista Capital and Health Evolution Part...